Apoptotic and anti-proliferative effects of all-trans retinoic acid. Adenine nucleotide translocase sensitizes HeLa cells to all-trans retinoic acid

Experimental Cell Research

Volumn 312, Issue 10, 2006, Pages 1813-1819

  Zamora, Mónica ^a   Ortega, Juan Alberto ^a   Alaña, Lide ^a   Viñas, Octavi ^a   Mampel, Teresa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenine nucleotide translocase; Apoptosis; ATP ADP translocase; Mitochondria; Proliferation; Retinoic acid

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CASPASE; CELL NUCLEUS RECEPTOR; ISOPROTEIN; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME INHIBITION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

ATRA;

EID: 33646843293     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.02.014     Document Type: Article

References (34)

1. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev., Cancer 1 (2001) 181-193
2. Abu J., Batuwangala M., Herbert K., and Symonds P. Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer. Lancet Oncol. 6 (2005) 712-720
3. Estey E., Koller C., Tsimberidou A.M., O'Brien S., Beran M., Cortes J., Tirado-Gomez M., Lopez-Berestein G., and Kantarjian H. Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid. Blood 105 (2005) 1366-1367
4. Testi A.M., Biondi A., Lo Coco F., Moleti M.L., Giona F., Vignetti M., Menna G., Locatelli F., Pession A., Barisone E., De Rossi G., Diverio D., Micalizzi C., Arico M., Basso G., Foa R., and Mandelli F. GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 106 (2005) 447-453
5. Gianni M., Ponzanelli I., Mologni L., Reichert U., Rambaldi A., Terao M., and Garattini E. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ. 7 (2000) 447-460
6. Adachi H., Adams A., Hughes F.M., Zhang J., Cidlowski J.A., and Jetten A.M. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways. Cell Death Differ. 5 (1998) 973-983
7. Wu S.J., Zhang D.M., Zhang Z.P., Soprano D.R., and Soprano K.J. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid. Oncogene 17 (1998) 2839-2849
8. Si S.P., Lee X.H., Tsou H.C., Buchsbaum R., Tibaduiza E., and Peacocke M. RAR beta 2-mediated growth inhibition in HeLa cells. Exp. Cell Res. 223 (1996) 102-111
9. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10 (1996) 940-954
10. Doerner A., Pauschinger M., Badorff A., Noutsias M., Giessen S., Schulze K., Bilger J., Rauch U., and Schultheiss H.P. Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett. 414 (1997) 258-262
11. Stepien G., Torroni A., Chung A.B., Hodge J.A., and Wallace D.C. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem. 267 (1992) 14592-14597
12. Dolce V., Scarcia P., Iacopetta D., and Palmieri F. A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett. 579 (2005) 633-637
13. Zoratti M., and Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta, Rev. Biomembr. 1241 (1995) 139-176
14. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., MacGregor G.R., and Wallace D.C. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427 (2004) 461-465
15. Halestrap A.P. Mitochondrial permeability: dual role for the ADP/ATP translocator?. Nature 430 (2004) 1
16. Notario B., Zamora M., Vinas O., and Mampel T. All-trans-retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition. Mol. Pharmacol. 63 (2003) 224-231
17. Rigobello M.P., Scutari G., Friso A., Barzon E., Artusi S., and Bindoli A. Mitochondrial permeability transition and release of cytochrome c induced by retinoic acids. Biochem. Pharmacol. 58 (1999) 665-670
18. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero-Otin M., Pamplona R., Vidal-Puig A.J., Wang S., Roebuck S.J., and Brand M.D. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22 (2003) 4103-4110
19. Nohl H., and Kramer R. Molecular-basis of age-dependent changes in the activity of adenine-nucleotide translocase. Mech. Ageing Dev. 14 (1980) 137-144
20. Chen J.J., Bertrand H., and Yu B.P. Inhibition of adenine-nucleotide translocator by lipid-peroxidation products. Free Radical Biol. Med. 19 (1995) 583-590
21. Belzacq A.S., El Hamel C., Vieira H.L., Cohen I., Haouzi D., Metivier D., Marchetti P., Brenner C., and Kroemer G. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene 20 (2001) 7579-7587
22. Boya P., Morales M.C., Gonzalez-Polo R.A., Andreau K., Gourdier I., Perfettini J.L., Larochette N., Deniaud A., Baran-Marszak F., Fagard R., Feuillard J., Asumendi A., Raphael M., Pau B., Brenner C., and Kroemer G. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 22 (2003) 6220-6230
23. Bauer M.K.A., Schubert A., Rocks O., and Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell Biol. 147 (1999) 1493-1501
24. Zamora M., Merono C., Vinas O., and Mampel T. Recruitment of NF-kappa B into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J. Biol. Chem. 279 (2004) 38415-38423
25. Zamora M., Granell M., Mampel T., and Vinas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett. 563 (2004) 155-160
26. Papazisis K.T., Geromichalos G.D., Dimitriadis K.A., and Kortsaris A.H. Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods 208 (1997) 151-158
27. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 (2000) 513-519
28. Wan Y.J.Y., Cai Y., Cowan C., and Magee T.R. Fatty acyl-CoAs inhibit retinoic acid-induced apoptosis in Hep3B cells. Cancer Lett. 154 (2000) 19-27
29. Hsu C.Y., and Yung B.Y.M. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int. J. Cancer 88 (2000) 392-400
30. Zhang H., Satyamoorthy K., Herlyn M., and Rosdahl I. All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells-A speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution. Carcinogenesis 24 (2003) 185-191
31. Jang J.Y., and Lee C.E. Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell. Immunol. 226 (2003) 11-19
32. Giraud S., Bonod-Bidaud C., Wesolowski-Louvel M., and Stepien G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J. Mol. Biol. 281 (1998) 409-418
33. Barath P., Luciakova K., Hodny Z., Li R., and Nelson B.D. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp. Cell Res. 248 (1999) 583-588
34. Chevrollier A., Loiseau D., Gautier F., Malthiery Y., and Stepien G. ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells. Mol. Carcinog. 42 (2005) 1-8